NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $953,002 | -4.1% | 9,356 | -5.0% | 0.36% | +1.7% |
| Q2 2023 | $994,165 | +8.3% | 9,852 | -1.3% | 0.36% | +8.1% |
| Q1 2023 | $918,068 | +4.1% | 9,979 | -14.0% | 0.33% | +5.7% |
| Q3 2022 | $882,000 | +24.6% | 11,605 | +38.6% | 0.31% | +15.9% |
| Q2 2022 | $708,000 | -30.7% | 8,372 | -28.1% | 0.27% | -9.1% |
| Q1 2022 | $1,022,000 | +39.6% | 11,643 | +39.1% | 0.30% | +20.6% |
| Q4 2021 | $732,000 | – | 8,372 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |